Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis

被引:47
作者
Dean, HJ [1 ]
Fuller, D [1 ]
Osorio, JE [1 ]
机构
[1] PowderJect Vaccines Inc, Madison, WI 53711 USA
关键词
vaccine; DNA vaccine; epidermis; immunization; influenza; human immunodeficiency virus; hepatitis B;
D O I
10.1016/S0147-9571(03)00021-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The epidermis of the skin is both a sensitive immune organ and a practical target site for vaccine administration. However, administration of vaccines into the epidermis is difficult to achieve using conventional vaccine delivery methods employing a needle and syringe. A needle-free vaccine delivery system has been developed that efficiently delivers powdered or particulate DNA and protein vaccines into the epidermal tissue. The delivery system can be used to directly transfect antigen presenting cells (APCs) by formulating DNA or protein vaccines onto gold particles (particle-mediated immunization). Antigen can be directly presented to the immune system by the transfected APCs. Antigen can also be expressed and secreted by transfected keratinocytes and picked up by resident APCs through the exogenous antigen presentation pathway. Alternatively, protein antigens can be formulated into a powder and delivered into the extracellular environment where they are picked up by APCs (epidermal powder immunization). Using any of these formulations, epidermal immunization offers the advantage of efficiently delivering vaccines into the APC-rich epidermis. Recent studies demonstrate that epidermal vaccine delivery induces humoral, cellular, and protective immune responses against infectious diseases in both laboratory animals and man. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:373 / 388
页数:16
相关论文
共 59 条
[1]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[2]   Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].
Allen, TM ;
Vogel, TU ;
Fuller, DH ;
Mothé, BR ;
Steffen, S ;
Boyson, JE ;
Shipley, T ;
Fuller, J ;
Hanke, T ;
Sette, A ;
Altman, JD ;
Moss, B ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978
[3]  
ANDRE FE, 1989, AM J MED S3A, V87, P14
[4]   Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines [J].
Arrington, J ;
Braun, RP ;
Dong, LC ;
Fuller, DH ;
Macklin, MD ;
Umlauf, SW ;
Wagner, SJ ;
Wu, MS ;
Payne, LG ;
Haynes, JR .
JOURNAL OF VIROLOGY, 2002, 76 (09) :4536-4546
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Oral mucosal Langerhans' cells [J].
Barrett, AW ;
Cruchley, AT ;
Williams, DM .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1996, 7 (01) :36-58
[7]  
BOX JD, 1997, CUTANEOUS IMMUNOLOGY
[8]   Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses [J].
Chen, D ;
Zuleger, C ;
Chu, Q ;
Maa, YF ;
Osorio, J ;
Payne, LG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (10) :715-722
[9]  
CHEN D, 2002, IN PRESS CELL RES, V13
[10]   Adjuvantation of epidermal powder immunization [J].
Chen, DX ;
Erickson, CA ;
Endres, RL ;
Periwal, SB ;
Chu, QL ;
Shu, C ;
Maa, YF ;
Payne, LG .
VACCINE, 2001, 19 (20-22) :2908-2917